Vaniqa
NDC Package 0023-4857-45

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Vaniqa is a medication used to slow down the growth of unwanted hair on the face and under the chin in women. Marketed by Allergan, Inc., this product is identified by NDC 0023-4857 and is authorized under FDA application NDA021145.

Identification & Billing

NDC Package Code
0023-4857-45
Package Description
1 TUBE in 1 CARTON / 45 g in 1 TUBE
Product Code
0023-4857
11-Digit Billing Format
00023485745
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
45 GM

Clinical Specifications

Proprietary Name
Vaniqa
Dosage Form
-
Usage Information
This medication is used to slow down the growth of unwanted hair on the face and under the chin in women. It should not be used for hair on other parts of the body. It blocks a certain natural substance (an enzyme) that is needed for hair growth in the skin. This effect slows hair growth and may also make the hair finer and lighter. It does not remove hair or cause the hair to fall out. This drug is not for use in children younger than 12 years.

Regulatory & Marketing

Labeler Name
Allergan, Inc.
FDA Application #
NDA021145
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-01-2013
End Marketing Date
10-31-2023
Listing Expiration
10-31-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0023-4857-45 identifies a specific commercial package of 1 tube in 1 carton / 45 g in 1 tube of Vaniqa, labeled by Allergan, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Allergan, Inc. on June 01, 2013. The current certification is valid through October 31, 2023.

What are the primary indications for this medication?

This medication is used to slow down the growth of unwanted hair on the face and under the chin in women. It should not be used for hair on other parts of the body. It blocks a certain natural substance (an enzyme) that is needed for hair growth in the skin. This effect slows hair growth and may also make the hair finer and lighter. It does not remove hair or cause the hair to fall out. This drug is not for use in children younger than 12 years.

How is this Allergan, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00023485745. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 45 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0023-4857-45
11-Digit CMS (5-4-2)
00023-4857-45

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.